97047 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
GENETICALLY ENGINEERED MESENCHYMAL STEM CELLS AND USES THEREOF
#2HUMAN-INDUCED PLURIPOTENT STEM CELL OVEREXPRESSING TLX AND USE THEREOF
#3COMPOSITIONS AND METHODS FOR MODULATING MOLECULES
#4CHIMERIC MODIFIED ION CHANNELS AND USES THEREOF FOR TREATMENT OF TRIGEMINAL NERVE DISORDERS
#5NR4A3-DEFICIENT IMMUNE CELLS AND USES THEREOF
#6mRNAS FOR TREATMENT OR PROPHYLAXIS OF LIVER DISEASES
#7COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS
#8SYSTEM AND METHOD FOR HOMOGENOUS GPCR PHOSPHORYLATION AND IDENTIFICATION OF BETA-2 ADRENERGIC RECEPTOR POSITIVE ALLOSTERIC MODULATORS
#9RECOMBINANT FUSION PROTEIN FOR PREVENTING OR TREATING FIBROTIC DISEASES
#10COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS
#11EXPRESSION SYSTEMS, RECOMBINANT CELLS AND USES THEREOF
#12Co-crystals of NURR1-lbd in complex with a cyclopentenone prostaglandin and modulators of NURR1
#13HYPOXIA-RESPONSIVE CHIMERIC ANTIGEN RECEPTORS
#14COMPOSITIONS AND METHODS FOR ENHANCING THE PLURIPOTENCY OF STEM CELLS
#15Breast and ovarian cancer vaccines
#16IN VIVO CONTROLLED COMBINATION THERAPY FOR TREATMENT OF CANCER
#17Breast and ovarian cancer vaccines
#18MONOCYTE MODULATION AND CONTROL OF TUMOR METASTASIS
#19Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#20PROTEIN-BASED MICELLES FOR THE DELIVERY OF HYDROPHOBIC ACTIVE COMPOUNDS
#21PEPTIDES FOR THE TREATMENT OF TYPE 2 DIABETES
#22PEPTIDES
#23Composition and method for inhibiting amyloid β accumulation and/or aggregation
#24Method to distinguish peroxisome proliferator-activated receptor gamma full agonist, partial agonist and antagonist with different activities and identification thereof
#25Breast and ovarian cancer vaccines
#26Co-crystals of Nurr1-LBD in complex with a cyclopentenone prostaglandin and modulators of Nurr1
#27Methods for enhancing the pluripotency of stem cells
#28Systems and methods for determining a treatment course of action
#29HEPATIC CELL LINE RESISTANT TO DIMETHYL SULFOXIDE, CELL CULTURE AND USES THEREOF
#30System and method for homogenous GPCR phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators
#31Novel Substitution Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System
#32TLX and MIR-219 as potential therapeutic targets for neurodevelopmental disorders
#33Inhibition and treatment of bacterial infections by sex-specific GPER targeting
#34LIGAND INDUCIBLE POLYPEPTIDE COUPLER SYSTEM
#35Vectors Conditionally Expressing Protein
#36Monocyte modulation and control of tumor metastasis
#37Methods for treating cancer with RORγ inhibitors
#38Therapeutic effects of NURR1 and FOXA2 in inflammatory neurologic disorders by M1-to-M2 polarization of glial cells
#39Breast and ovarian cancer vaccines
#40Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System
#41Novel Ecdysone Receptor/Invertebrate Retinoid X Receptor-Based Inducible Gene Expression System
#42Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#43Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
#44Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#45Methods and compositions of predicting activity of retinoid X receptor modulator
#46Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#47Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL
#48Androgen receptor variants and methods for making and using
#49Systems and methods for determining a treatment course of action
#50Methyl degron peptide and methods of controlling protein lifespan
#51Compositions for enhancing the pluripotency of stem cells
#52Vectors conditionally expressing protein
#53COMPOSITIONS AND METHODS RELATED TO PROSTATE CANCER
#54Steroidal ligands and their use in gene switch modulation
#55Methods and composition for measuring the amount of vitamin D derivatives
#56Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#57Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System
#58Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (TIx)
#59Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#60Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
#61LIGAND BINDING DOMAINS OF NUCLEAR RECEPTORS IN CONTROLLABLE FORM AND METHODS INVOLVING THE SAME
#62Co-crystallization of ERR-α with a ligand that forms a reversible covalent bond
#63Ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
#64Productivity augmenting protein factor, novel cell lines and uses thereof
#65METHODS AND COMPOSITIONS FOR PROGNOSING AND DETECTING AGE-RELATED MACULAR DEGENERATION
#66ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER
#67COMPOSITIONS AND METHODS FOR DEMONSTRATING SECRETORY IMMUNE SYSTEM REGULATION OF STEROID HORMONE RESPONSIVE CANCER CELL GROWTH
#68Methods and composition for measuring the amount of Vitamin D derivatives
#69ROR ALPHA PROMOTING THE INDUCTION OF BMALL
#70BREAST CANCER ERADICATION PROGRAM
#71Receptor gene screening for detecting or diagnosing cancer
#72Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL
#73Agonists of NR2F6 For Immunosupression
#74Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
#75AGENT FOR PROMOTING NEURONAL DIFFERENTIATION AND METHOD THEREFOR
#76LIGAND BINDING DOMAINS OF NUCLEAR RECEPTORS IN CONTROLLABLE FORM AND METHODS INVOLVING THE SAME
#77SCREENING FOR NON-GENOTOXIC CARCINOGENS
#78SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER
#79Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
#80LXR LIGAND BINDING DOMAIN (LXR LBD) CRYSTALS
#81Targeting of Notch3 Receptor Function for Cancer Therapy
#82Co-crystallization of ERR-α with a ligand that forms a reversible covalent bond
#83Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx)
#84Structure of the farnesoid X receptor ligand binding domain and methods of use therefor
#85Screening method for predicting susceptibility to breast cancer
#86Anti-estrogen and immune modulator combinations for treating breast cancer
#87METHODS OF REGULATING APOPTOSIS
#88Crystal of pregnane X receptor fused to steroid receptor coactivator-1
#89ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) IN BONE AND CARTILAGE FORMATION AND METHODS AND COMPOSITIONS RELATING TO SAME
#90Breast cancer eradication program
#91Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules
#92Method of evaluating metabolism of the eye
#93Steroidal ligands and their use in gene switch modulation
#94ROR-alpha Promoting the Induction of Bmall
#95Materials and methods relating to the production and maintenance of cell lines
#96Rhesus monkey Nur77
#97TYROSINE KINASE INHIBITOR COMPOSITIONS AND METHODS FOR MANUFACTURING AND USING THEM IN THE TREATMENT OF DISEASE
#98Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#99Nucleic acid molecule encoding a novel estrogen receptor beta variant
#100Targeting of Notch3 receptor function for cancer therapy
#101Cancer-suppressing agents
#102Nucleic acid molecule encoding a novel estrogen receptor beta variant
#103Cancer-suppressing agents
#104Ligand activated transcriptional regulator proteins
#105BISPECIFIC ANTIBODIES
#106Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#107Method for activating efferent sympathetic nerves innervating adipose tissues to improve obesity and symptoms associated therewith
#108Ligand for G-protein coupled receptor GPR43 and uses thereof
#109Non-human organism comprising a gene expression modulation system encoding a chimeric retinoid X receptor
#110Crystal structure of estrogen receptor-beta complex and uses thereof
#111BREAST CANCER ERADICATION PROGRAM
#112Chimeric binding peptide library screening method
#113Modulation of the Expression of Estrogen Receptors for the Prevention or Treatment of Heart Disease
#114Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system
#115Hepatocytes
#116Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#117Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#118Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard)
#119Cancer-suppressing agents
#120Novel human LXRalpha variants
#121Neurite regeneration
#122Nezara viridula Ecdysone Receptor
#123Method for producing immortalised antibodies-secreting cells
#124Orthogonal gene switches
#125Protein crystal
#126Compounds that regulate apoptosis
#127Modulation of peroxisome proliferator-activated receptors
#128Methods for modulating transcriptional activation using mint proteins
#129Steroid-activated nuclear receptors and uses therefor
#130Proliferator-Activated Receptor Disruptions, Compositions and Methods Relating Thereto
#131Method for modulating process mediated by farnesoid activated receptors
#132SCREENING SYSTEMS AND METHODS FOR IDENTIFYING MODULATORS OF XENOBIOTICMETABOLISM
#133Retinoid X receptor-interacting polypeptides and related molecules and methods
#134Nucleic acid construct, metabolic disordered non-human animal and use thereof
#135Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses therefor
#136Crystallized structure of estrogen related receptor gamma in complex with bisphenol A
#137Peroxisome proliferator-activated receptor
#138Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
#139Neural crest cells specific promoters; isolated neural crest cells; and methods of isolating and of using same
#140Rhesus monkey Nur77
#141Tr2, tr4, tr2/tr4 double knockouts and uses thereof
#142Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
#143Bacterial ligand-binding sensor
#144Structure of the farnesoid X receptor ligand binding domain and methods of use therefor
#145Identification of a synthetic ligand for retinoic acid receptor beta
#146Method of screening drug
#147Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions
#148Transgenic mice containing, cGMP phosphodiesterase gene disruptions
#149Human nuclear receptor protein nNR7-1
#150SF-1 and LRH-1 modulator development
#151Novel members of the steroid/thyroid superfamily and uses therefor
#152Materials and methods relating to the production and maintenance of cell lines
#153Transgenic mice containing sulfotransferase gene disruptions
#154Nuclear receptor err y 3
#155Transgenic mice containing chordin gene disruptions
#156Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
#157Prolactin receptor gene as a genetic marker for increased litter size in animals
#158Use of nuclear hormone receptors
#159Tr4/tr2 response elements
#160Retinoic acid receptor beta-2, its agonists, and gene therapy vectors for the treatment of neurological disorders
#161Orphan receptor TLX and uses therefor
#162Rhesus monkey NURR1 nuclear receptor
#163Novel human estrogen receptor beta
#164Ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3) and uses thereof
#165ISOFORMS OF NUCLEAR RECEPTOR RXR a
#166Compositions and methods of modulating cholesterol metabolism
#167Gene screening method using nuclear receptor
#168Method of evaluating metabolism of the eye
#169Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha)
#170Orphanin FQ receptor polypeptides
#171Estrogen receptor genes and utilization thereof
#172Novel plamid DNA comprising reoprter gene DNA and use of the same
#173Gene screening method using nuclear receptor
#174Bispecific antibodies
#175Mutated constitutively active nuclear orphan receptor
#176Human LXRα variants
#177Novel cell-surface estrogen receptor and related compositions and methods
#178Modulation of the expression of estrogen receptors for the prevention or treatment of heart disease
#179Gene screening method using nuclear receptor
#180Method of screening for an agent that enhances beige fat adipogenesis